In the present study, avadomide showed anti-tumor effects on PDAC cells in vitro and in vivo, particularly on GR PDAC clones, via repression of transcription through NF-κB process inhibition and cell cycle arrest by increased expression of CDK inhibitors. This evidence concerns the gene NFKB1 and neoplasm.